Becker's Healthcare January 4, 2022
The FDA has published a draft document that advises on the use of digital health tools in acquiring data from participants in clinical investigations that evaluate medical products.
In the document, issued Jan. 3, the agency says advances in technology have boosted the power of data collection methodology in clinical investigations and allow for more detailed recordings of participants’ daily lives.
“Compared to intermittent trial visits,...